All articles tagged: Pharmacy
HealthDay
06 September at 09.57 PM
6.7 Percent of U.S. Adults Cannot Use Automatic BP Devices Due to Arm SizeAn estimated 6.7 percent of U.S. adults cannot use popular automatic blood pressure devices due to arm circumference, according to a research letter published online Sept. 5 in Hypertension to coincide with the American Heart Association Hypertension 2024 Scientific Sessions, held from Sept. 5 to 8 in Chicago.Eileen Kaur, from |
HealthDay
06 September at 09.37 PM
Socioeconomic Disparities Impact Immunotherapy Use in Urologic CancersImmunotherapy (IO) utilization is increasing over time, but significant socioeconomic disparities exist for patients with advanced clear cell renal cell carcinoma (ccRCC) and urothelial carcinoma of the bladder (UC), according to a study published in the November issue of Urologic Oncology: Seminars and Original Investigations.Levi Holl |
HealthDay
06 September at 03.45 PM
Machine Learning Can ID Risk for Persistent Opioid Use After SurgeryMachine learning can identify patients who are at risk for persistent opioid use after surgery, according to a study published in the September issue of Plastic and Reconstructive Surgery.Natalie B. Baxter, from the University of Michigan Medical School in Ann Arbor, and colleagues trained two algorithms to predict persistent opioid use |
HealthDay
06 September at 03.09 PM
Adjunctive IV Argatroban, Eptifibatide Do Not Cut Disability After StrokeAdjunctive treatment with intravenous argatroban or eptifibatide does not reduce poststroke disability among patients with acute ischemic stroke treated with intravenous thrombolysis within three hours after symptom onset, according to a study published in the Sept. 5 issue of the New England Journal of Medicine.Opeolu Adeoye, M.D., fro |
HealthDay
05 September at 10.41 PM
Lower Uptake of HPV Vaccine Seen for Girls With Mental IllnessGirls with mental illness and neurodevelopmental conditions have lower uptake of human papillomavirus (HPV) vaccination, according to a study published in the September issue of The Lancet Public Health.Kejia Hu, Ph.D., from the Karolinska Institutet in Stockholm, and colleagues conducted a population-based cohort study to examine the |
HealthDay
05 September at 10.38 PM
Doxorubicin + Trabectedin Tied to Increased Survival in Metastatic LeiomyosarcomaFor patients with metastatic or surgically unresectable leiomyosarcoma, combination therapy with doxorubicin and trabectedin is associated with improved overall and progression-free survival compared with doxorubicin alone, according to a study published online Sept. 4 in the New England Journal of Medicine.Patricia Pautier, M.D., fro |
HealthDay
05 September at 10.35 PM
RSV Vaccination Effective Against Hospitalization in Patients 60 Years and OlderFor older adults, respiratory syncytial virus (RSV) vaccination is effective against RSV hospitalization, according to a study published online Sept. 4 in the Journal of the American Medical Association.Diya Surie, M.D., from the U.S. Centers for Disease Control and Prevention in Atlanta, and colleagues examined RSV vaccine effectiven |
HealthDay
05 September at 03.06 PM
Report Reveals Extent of Cost-Related Medication Nonadherence in SeniorsAbout 3.5 percent of older adults do not take prescription medications due to cost and a similar percentage do not take medications as prescribed due to cost, according to a study published online Sept. 5 in the National Health Statistics Reports, a publication from the National Center for Health Statistics.Robin A. Cohen, Ph.D., |
HealthDay
05 September at 10.23 AM
Amid Shortages, U.S. Allows Expanded Production of ADHD Drug VyvanseThe maker of the ADHD drug Vyvanse has been given approval by the U.S. Drug Enforcement Administration to make more of the medication as a shortage of the critical drugs continues.Following a request from the U.S. Food and Drug Administration in July, the DE |
HealthDay
04 September at 11.06 PM
Monoclonal Antibody Tops Placebo for Reducing Migraine FrequencyThe humanized monoclonal antibody directed against the pituitary adenylate cyclase-activating polypeptide (PACAP) ligand, Lu AG09222, is better than placebo for reducing migraine frequency over four weeks, according to a study published in the Sept. 5 issue of the New England Journal of Medicine.Messoud Ashina, M.D., from Copenhagen |
HealthDay
04 September at 03.10 PM
First-Generation Antihistamines Increase Risk for Seizures in ChildrenFirst-generation antihistamines are associated with a higher seizure risk in young children, according to a study published online Aug. 28 in JAMA Network Open.Ju Hee Kim, M.D., from the Kyung Hee University Medical Center in Seoul, South Korea, and colleagues evaluated associations between prescriptions of first-generation anti |
HealthDay
04 September at 03.06 PM
Asthma Inhalers Tied to Large Greenhouse Gas Emissions ProductionInhaler devices are a substantial source of greenhouse gas emissions in the United States, according to a research letter published online Aug. 29 in the Journal of the American Medical Association.Jyothi Tirumalasetty, M.D., from the Stanford University School of Medicine in California, and colleagues assessed mean emissions in |
HealthDay
03 September at 08.11 PM
Time From Drug Approval to Reimbursement Longer in U.S. Than Some European CountriesTime from approval to reimbursement of new drugs varies between countries and is shortest in Switzerland and Germany, both of which include health technology assessment decisions that are not used in the United States, according to a study published online Sept. 3 in the Annals of Internal Medicine.Camille E.G. Glaus, J.D., from the Un |
HealthDay
03 September at 08.11 PM
SGLT-2 Inhibitors May Cut Dementia Risk in Patients With DiabetesSodium-glucose cotransporter-2 (SGLT-2) inhibitors may prevent dementia in middle-aged adults with diabetes, according to a study published online Aug. 28 in The BMJ.Anna Shin, from Seoul National University Bundang Hospital in South Korea, and colleagues compared the risk for dementia associated with SGLT-2 inhibitors versus dipe |
HealthDay
03 September at 08.09 PM
Hormone Therapy Tied to Less Biological Aging in Postmenopausal WomenPostmenopausal women who use hormone therapy (HT) are biologically younger than those not receiving HT, according to a study published online Aug. 29 in JAMA Network Open.Yufan Liu and Chenglong Li, Ph.D., from Peking University in Beijing, evaluated the association between HT use and discrepancies between chronological and biolog |
HealthDay
30 August at 10.57 PM
Home Administration of Misoprostol Safe, EffectiveHome administration of misoprostol significantly increases the proportion of day-care procedures in medical abortion after 12 gestational weeks, according to a study published in the Aug. 31 issue of The Lancet.Johanna Rydelius, M.D., from the University of Gothenburg in Sweden, and colleagues evaluated whether administering the first m |
HealthDay
30 August at 03.06 PM
Dietary Vitamin E May Be Protective Against Atopic DermatitisDietary intake of vitamin E may potentially lower the risk for atopic dermatitis, according to a study published online Aug. 9 in Skin Research & Technology.Siqing Wang, from the Beijing University of Chinese Medicine, and colleagues conducted a Mendelian randomization analysis to explore the causal relationship between dietary |
HealthDay
29 August at 03.59 PM
Naloxone Aids Out-of-Hospital Cardiac Arrest Outcomes, Regardless of Drug UseRegardless of drug use, administration of naloxone during out-of-hospital cardiac arrest (OHCA) is associated with improved outcomes, such as increased survival to hospital discharge, according to a study published online Aug. 20 in JAMA Network Open.David G. Dillon, M.D., Ph.D., from the University of California, Davis, and coll |
HealthDay
29 August at 03.56 PM
Fewer Complications at 18 Months Seen With Post-COVID-19 Vaccination MyocarditisPatients with post-COVID-19 mRNA vaccination myocarditis show a lower frequency of cardiovascular complications than those with conventional myocarditis or post-COVID-19 myocarditis at 18 months, according to a study published online Aug. 26 in the Journal of the American Medical Association.Laura Semenzato, from the French Natio |
HealthDay
29 August at 03.46 PM
People With Xylazine Wounds Face Barriers to Seeking Wound CarePeople with self-identified xylazine wounds are more likely to engage in subcutaneous injection and face several barriers to seeking medical wound treatment, according to a study published online Aug. 21 in Drug and Alcohol Dependence.Raagini Jawa, from the University of Pittsburgh School of Medicine, and colleagues sought to und |
HealthDay
28 August at 10.04 PM
Ubrogepant Administered During Prodrome Beneficial for MigraineFor adults experiencing migraine attacks with moderate-to-severe headache pain, ubrogepant administered during prodrome is beneficial for patient-reported outcomes, according to a study published online Aug. 28 in Neurology.Richard B. Lipton, M.D., from the Albert Einstein College of Medicine in Bronx, New York, and colleagues conduc |
HealthDay
28 August at 04.03 PM
RSV Infection With Inflammatory Bowel Disease Ups Risk for HospitalizationAdult patients with inflammatory bowel disease (IBD) and respiratory syncytial virus (RSV) infection have an increased risk for hospitalization, according to a study published online in the August issue of The American Journal of Gastroenterology.Ryan A. Smith, M.D., from University of Wisconsin in Madison, and colleagu |
HealthDay
28 August at 03.54 PM
Psilocybin Has Better Response Than Placebo in Antidepressant TrialsPatients treated with high-dose psilocybin have better responses than those treated with placebo in antidepressant trials, according to a study published online Aug. 21 in The BMJ.Tien-Wei Hsu, M.D., from E-DA Dachang Hospital in Kaohsiung, Taiwan, and colleagues examined the comparative effectiveness and acceptability of oral monoth |
HealthDay
28 August at 03.04 PM
Cholinesterase Inhibitors Beneficial for Dementia With Lewy BodiesCholinesterase inhibitors (ChEIs) are beneficial for patients with dementia with Lewy bodies (DLB), according to a study published online Aug. 23 in Alzheimer's & Dementia.Hong Xu, M.D., Ph.D., from the Center for Alzheimer Research at the Karolinska Institutet in Stockholm, and colleagues examined the impact of ChEIs and memanti |
HealthDay
28 August at 03.02 PM
Increasing Thiazide Dose Linked to Greater Reduction in CalciumFor adults with kidney stones, increasing thiazide dose is associated with greater reductions in calcium, which are negatively associated with symptomatic stone events, according to a research letter published online Aug. 22 in JAMA Network Open.Ryan S. Hsi, M.D., from the Vanderbilt University Medical Center in Nashville, Tennessee, |
HealthDay
28 August at 02.58 PM
Semaglutide Reduces Risk for MACE in Patients With Obesity and Heart FailureSemaglutide reduces the risk for major adverse cardiovascular events (MACE) and composite heart failure end points compared with placebo in patients with overweight or obesity and heart failure, according to a study published online Aug. 24 in The Lancet.John Deanfield, B.Chir., M.B., from the Institute of Cardiovascular Sciences at |
HealthDay
27 August at 09.55 PM
Pharmacy Deserts Also Face Social Vulnerability, Lack of Health Care ProvidersCounties with high pharmacy desert densities also face social vulnerability and health care provider shortages, according to a research letter published online Aug. 23 in JAMA Network Open.Giovanni Catalano, M.D., from The Ohio State University Wexner Medical Center in Columbus, and colleagues examined if pharmacy deserts dispropo |
HealthDay
27 August at 09.47 PM
FDA Expands Approval of Omnipod 5 Insulin Delivery System to Include Patients With Type 2 DiabetesOn Monday, the U.S. Food and Drug Administration approved the Insulet Omnipod 5 insulin delivery system for patients with type 2 diabetes. It is the first such system for use by people with the more prevalent form of the disease.The FDA first signed off on the system, which automatically adjusts insulin delivery as needed, for type 1 diabetes i |
HealthDay
27 August at 03.55 PM
Lecanemab-Labeled Amyloid Plaques Identified in Down SyndromeIn middle-aged individuals with Down syndrome (DS), lecanemab-labeled amyloid plaques are seen in postmortem brain tissue analysis, in addition to extensive binding to brain blood vessels, according to a study published online Aug. 19 in JAMA Neurology.Lei Liu, M.D., Ph.D., from Brigham and Women's Hospital in Boston, and colleagues ex |
HealthDay
27 August at 03.42 PM
Elinzanetant Efficacious, Well-Tolerated for Vasomotor SymptomsFor menopausal vasomotor symptoms (VMS), elinzanetant is efficacious and well-tolerated, according to a study published online Aug. 22 in the Journal of the American Medical Association.JoAnn V. Pinkerton, M.D., from the University of Virginia Health in Charlottesville, and colleagues examined the efficacy and safety of elinzanetant, a |
HealthDay
27 August at 02.12 PM
Weight-Loss Drug Zepbound Now in Single-Dose Vials at Half the PriceEli Lilly, maker of one of the blockbuster GLP-1 weight-loss drug Zepbound, says it will now offer the medication in single-dose vials at half the price currently available to consumers.The new 2.5 milligram (mg) and 5 mg weekly dose vials differ from the standard preloaded injector pens that are used to administer Zepbound (tirzepatide) and co |
HealthDay
27 August at 10.57 AM
WHO Unveils Plan to End African Mpox OutbreakAs an mpox outbreak continues to rage in Africa, the World Health Organization on Monday launched a six-month plan to quell its spread.“The mpox outbreaks in the Democratic Republic of the Congo and neighboring countries can be controlled, and can be stopped,” WHO Director-General <a href="https://blogs.worldbank.org/en/team/t/tedros-adhanom-gh |
HealthDay
26 August at 09.50 PM
After Weighting, 3.6 Million Likely to Be Newly Eligible for SemaglutideIncreases in eligibility for semaglutide are discussed in a research letter published online Aug. 27 in the Annals of Internal Medicine.After the Semaglutide Effects on Heart Disease and Stroke in Patients With Overweight or Obesity trial showed that semaglutide reduced cardiovascular events in certain patients without diabetes, Medicar |
HealthDay
26 August at 09.45 PM
Risk for Dementia Similar With SGLT2 Inhibitors, Dulaglutide in T2DMFor older adults with type 2 diabetes, the risk for dementia seems similar with sodium-glucose cotransporter 2 (SGLT2) inhibitors and the glucagon-like peptide 1 receptor agonist (GLP-1 RA) dulaglutide, according to a study published online Aug. 27 in the Annals of Internal Medicine.Bin Hong, from the School of Pharmacy at Sungkyunkwan |
HealthDay
26 August at 09.19 PM
Most Americans Unprepared to Handle Opioid OverdosesMore than three in four people (77 percent) say they would not know how to respond if they saw someone having an opioid overdose, according to survey results from The Ohio State University."While I'm not surprised about this result, I am deeply concerned because we know that the more of us who are prepared to save a life, the more lives we can s |
HealthDay
26 August at 02.26 PM
Vaccination Coverage for Teens Similar in 2023 and 2022In 2023, vaccination coverage for adolescents with all routine vaccines was similar to coverage in 2022, according to research published in the Aug. 22 issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report.Cassandra Pingali, M.P.H., from the CDC in Atlanta, and colleagues analyzed data from t |
HealthDay
26 August at 02.01 PM
Olaparib Monotherapy Yields Good PSA Response Rates in Prostate CancerFor men with high-risk biochemically recurrent prostate cancer, olaparib monotherapy yields good prostate-specific antigen (PSA) response rates, especially among those with BRCA2, according to a study published online Aug. 22 in JAMA Oncology.Catherine H. Marshall, M.D., from the Johns Hopkins University School of Medicine in B |
HealthDay
26 August at 10.50 AM
U.S. Will Offer Free COVID Tests By Mail by Late SeptemberAs a summer surge in COVID cases begins to ebb and Americans brace themselves for yet another wave of infections this winter, more free COVID tests will soon be available to all, federal health officials announced Friday.Starting in late September, every U.S. household can order up to four nasal swab tests when the federal program reopens, accor |
HealthDay
23 August at 10.39 PM
Type 2 Diabetes Prevalence Rose in the United States From 2012 to 2022The prevalence of diabetes increased in the United States from 2012 to 2022, according to a research letter published online July 18 in Diabetes, Obesity and Metabolism.Sulakshan Neupane, from the University of Georgia in Athens, and colleagues examined recent national trends and disparities in self-reported diabetes prevalence amo |
HealthDay
23 August at 03.44 PM
Socially, Economically Disadvantaged Communities Lack Access to BuprenorphineRestricted buprenorphine dispensing was most pronounced in socially and economically disadvantaged communities, according to a study published in the September issue of Drug and Alcohol Dependence Reports.Kyle J. Moon, from the Johns Hopkins Bloomberg School of Public Health in Baltimore, and colleagues conducted a U.S. telephone a |
HealthDay
23 August at 03.16 PM
Belzutifan Improves Progression-Free Survival in Advanced Renal Cell CancerBelzutifan, a hypoxia-inducible factor 2α (HIF-2α) inhibitor, improves progression-free survival and objective responses over everolimus among patients with advanced clear-cell renal cell carcinoma, according to a study published in the Aug. 22 issue of the New England Journal of Medicine.Toni K. Choueiri, M.D., from the Dana-Farber Can |
HealthDay
22 August at 06.40 PM
FDA Approves Updated COVID Shots for FallUpdated shots to shield against COVID-19 infection were approved by the U.S. Food and Drug Administration on Thursday.This year's approval for the updated mRNA vaccines comes much sooner than happened in 2023, when fall vaccines were authorized on Sept. 1 |
HealthDay
21 August at 03.20 PM
Semaglutide-Linked Suicidal Ideation ID'd in Disproportionality AnalysisSemaglutide-associated suicidal ideation has been identified in a disproportionality analysis, according to a study published online Aug. 20 in JAMA Network Open.Georgios Schoretsanitis, M.D., Ph.D., from Northwell Health in Glen Oaks, New York, and colleagues examined potential signals for suicidal and self-injurious adverse drug re |
HealthDay
20 August at 08.49 PM
This Week Could Bring FDA Approval of Fall COVID-19 VaccinesUpdated COVID-19 vaccines may receive approval from the U.S. Food and Drug Administration this week.Two sources familiar with the issue told CNN that updated mRNA vaccines from Moderna and Pfizer that target the KP.2 variant could be greenlit as early as this week. The news agency said the sources declined to be named because informati |
HealthDay
16 August at 09.19 PM
Acceptable Liver Transplant Outcomes Seen After ICI Therapy for Liver CancerFor patients with hepatocellular carcinoma (HCC), immune checkpoint inhibitor (ICI) use prior to liver transplant (LT) does not worsen outcomes, according to research published online July 10 in the Journal of Hepatology.Mohammad Saeid Rezaee-Zavareh, from the Middle East Liver Diseases Center in Tehran, Iran, and colleagues summarized |
HealthDay
16 August at 03.11 PM
Maternal Epilepsy Tied to Increased Maternal Morbidity, Perinatal Mortality and MorbidityWomen with epilepsy have a considerably higher risk for severe maternal and perinatal outcomes and an increased risk for death during pregnancy and postpartum, according to a study published online Aug. 5 in JAMA Neurology.Neda Razaz, Ph.D., from the Karolinska Institutet in Stockholm, and colleagues examined associations between m |
HealthDay
15 August at 10.00 PM
FDA Approves Nemluvio for Prurigo NodularisThe U.S. Food and Drug Administration has approved Nemluvio (nemolizumab) for adult patients living with prurigo nodularis.Nemluvio, administered as a prefilled pen for subcutaneous injection, inhibits interleukin-31 cytokine signaling, which is known to drive itch and is involved in inflammation, altered epidermal differentiation, and fibrosi |
HealthDay
15 August at 03.16 PM
ADHD Medications Also Improve Quality of LifeMedications for attention-deficit/hyperactivity disorder (ADHD) are effective at improving quality of life in people with the disorder, according to a review recently published in the Journal of the American Academy of Child & Adolescent Psychiatry.Alessio Bellato, Ph.D., from the University of Southampton in the United Kingd |
HealthDay
15 August at 03.13 PM
Problematic Pharmaceutical Opioid Use Common in Noncancer PainFor individuals with chronic noncancer pain (CNCP) treated with opioid analgesics, problematic pharmaceutical opioid use (POU) is common, according to a study published online Aug. 7 in Addiction.Kyla H. Thomas, Ph.D., M.B.B.S., from the University of Bristol in the United Kingdom, and colleagues conducted a comprehensive systematic l |
HealthDay
15 August at 11.36 AM
New Deals Will Cut Medicare Costs for Expensive DrugsThe Biden administration said Thursday that it has signed deals with drug companies that will lower the prices on 10 of the most popular and expensive drugs used by American seniors.Taxpayers should save $6 billion because of the new prices, while seniors using Medicare could save roughly $1.5 billion on their medications, the U.S. Centers for |
HealthDay
14 August at 10.28 PM
Vaccines for Children Program Has Increased Coverage, but Gaps RemainThe Vaccines for Children (VFC) program, which provides recommended vaccines at no cost to eligible children, has increased childhood vaccination coverage, but coverage is still lower than among non-VFC-eligible children, according to a Vital Signs report published Aug. 13 in the U.S. Centers for Disease Control and Prevention Morbidity |
HealthDay
14 August at 10.22 PM
Most Patients With MS Have No Risk for Relapse After COVID-19 VaccinationFor most patients with multiple sclerosis (MS), there is no increased risk for relapse after COVID-19 vaccination, according to a study published online Aug. 14 in Neurology.Xavier Moisset, M.D., Ph.D., from the Universite Clermont Auvergne in Clermont-Ferrand, France, and colleagues conducted a nationwide study using data from the F |
HealthDay
14 August at 03.53 PM
Past-Month Cannabis Use Increasing Among Adults With DiabetesAmong U.S. adults with diabetes, cannabis use in the past month increased by 33.7 percent from 2021 to 2022, according to a research letter published online July 22 in Diabetes Care.Benjamin H. Han, M.D., M.P.H., from the University of California, San Diego, School of Medicine in La Jolla, and colleagues estimated the most recent nat |
HealthDay
14 August at 03.43 PM
Fish Oil Supplements Counteract Genetic Predisposition to High CholesterolFish oil seems to counteract genetic predisposition to high cholesterol, according to a study published online July 15 in the American Journal of Clinical Nutrition.Yitang Sun, Ph.D., from the Franklin College of Arts and Sciences at the University of Georgia in Athens, and colleagues examined whether fish oil supplementation mo |
HealthDay
14 August at 03.37 PM
Sacituzumab Govitecan Shows Promise in Advanced Endometrial CancerFor patients with advanced endometrial cancer (EC), sacituzumab govitecan (SG), a trophoblast cell-surface antigen 2 (Trop-2)-directed antibody-drug conjugate, shows encouraging efficacy, according to a phase 2 study published online July 31 in the Journal of Clinical Oncology.Alessandro D. Santin, M.D., from the Yale School of Medic |
HealthDay
12 August at 09.50 PM
GLP-1 RA Use Linked to Lower Rates of Hyperkalemia in Type 2 DiabetesTreatment with glucagon-like peptide 1 receptor agonists (GLP-1 RAs) is associated with lower rates of hyperkalemia and a lower rate of renin-angiotensin system inhibitor (RASi) discontinuation compared with treatment with dipeptidyl peptidase-4 inhibitors (DPP-4is) among patients with type 2 diabetes (T2D), according to a study published online Aug. 1 |
HealthDay
12 August at 09.46 PM
Buprenorphine + Naloxone Safe for Opioid Addiction in PregnancyPregnancies exposed to buprenorphine combined with naloxone have similar or more favorable neonatal and maternal outcomes as those exposed to buprenorphine alone, according to a study published online Aug. 12 in the Journal of the American Medical Association.Loreen Straub, M.D., from Brigham and Women's Hospital and Harvard Medical Sch |
HealthDay
12 August at 04.11 PM
Risks for Mortality, Adverse Heart, Kidney Events Lower With Tirzepatide for T2DMFor patients with type 2 diabetes, treatment with tirzepatide (a dual glucagon-like peptide 1 and glucose-dependent insulinotropic polypeptide receptor agonist) is associated with lower risks for all-cause mortality and adverse cardiovascular and kidney events compared with glucagon-like peptide 1 receptor agonist treatment (GLP-1 RA), according to a s |
HealthDay
12 August at 03.54 PM
Dupilumab Maintains Its Effectiveness Up to Five Years in Patients With EczemaFor patients with atopic dermatitis (AD), dupilumab maintains its clinical effectiveness up to five years and is discontinued by 23.8 percent of patients, according to a study published online Aug. 7 in JAMA Dermatology.Celeste M. Boesjes, M.D., from the University Medical Center Utrecht in the Netherlands, and colleagues examined clini |
HealthDay
12 August at 03.47 PM
Gene Expression Signature Predicts Immune-Related Adverse Events in Melanoma PatientsA gene expression signature in peripheral CD4+ T-cells can predict severe immune-related adverse events (irAEs) among melanoma patients treated with ipilimumab/nivolumab, according to a study published online Aug. 8 in Clinical Cancer Research.Kelsey R. Monson, Ph.D., from the Perlmutter Cancer Center at NYU Langone Health in |
HealthDay
12 August at 03.44 PM
Commonly Prescribed Antibiotics Linked to Cutaneous Adverse Drug ReactionsSulfonamide antibiotics and cephalosporins are most strongly associated with serious cutaneous adverse drug reactions (cADRs), according to a study published online Aug. 8 in the Journal of the American Medical Association.Erika Y. Lee, M.D., from the University of Toronto, and colleagues explored the risk for serious cADRs associated w |
HealthDay
12 August at 10.57 AM
FDA Says No to MDMA as Therapy for PTSDAdvocates for the use of the psychedelic drug MDMA (midomafetamine) to treat mental health conditions were delivered a setback on Friday after the U.S. Food and Drug Administration declined to approve it as treatment for post-traumatic stress disorder (PTSD).There is insufficient evidence that MDMA -- currently illegal and also known as Ecstasy |
HealthDay
09 August at 03.40 PM
FDA Approves Voranigo for Grade 2 Astrocytoma or OligodendrogliomaThe U.S. Food and Drug Administration has approved Voranigo (vorasidenib) for grade 2 astrocytoma or oligodendroglioma with a susceptible mutation.The isocitrate dehydrogenase-1 (IDH1) and isocitrate dehydrogenase-2 (IDH2) inhibitor is approved for adult and pediatric patients ages 12 years and older with grade 2 astrocytoma or oligodendroglioma |
HealthDay
09 August at 03.34 PM
Childhood Vaccinations Have Prevented ~508 Million Lifetime Cases of IllnessChildhood vaccinations continue to provide substantial health and economic benefits, according to research published in the Aug. 8 issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report.Noting that the U.S. Vaccines for Children (VFC) program has covered the cost of vaccines for children whose |
HealthDay
09 August at 03.30 PM
CDC Updates Practice Recommendations for ContraceptivesIn two practice recommendations published in the Aug. 8 issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report, updated recommendations are presented relating to use of specific contraceptive methods and for persons with certain characteristics or medical conditions.Kathryn M. Curtis, Ph.D., fr |
HealthDay
08 August at 04.04 PM
Long-Acting Cabotegravir Well Tolerated in Pregnant WomenLong-acting injectable cabotegravir (CAB-LA) appears to be well tolerated in pregnant women, according to a study presented at AIDS 2024, the 25th International AIDS Conference, held from July 22 to 26 in Munich.Sinead Delany-Moretlwe, M.B.B.Ch., Ph.D., from the University of the Witwatersrand in South Africa, and colleagues reported on materna |
HealthDay
08 August at 04.00 PM
Abacavir Use Linked to Increased Incidence of MACEFor patients with HIV in the Randomized Trial to Prevent Vascular Events in HIV (REPRIEVE) trial, use of abacavir was associated with an increased incidence of major adverse cardiovascular events (MACE), according to a study presented at AIDS 2024, the 25th International AIDS Conference, held from July 22 to 26 in Munich.Carl J. Fichtenbaum, M. |
HealthDay
08 August at 03.48 PM
Interprofessional Addiction Consultation Ups Medication for Opioid Use DisorderInterprofessional addiction consultation services significantly increase postdischarge medication for opioid use disorder (MOUD) initiation and engagement among patients with opioid use disorder, according to a study published online July 29 in JAMA Internal Medicine.Jennifer McNeely, M.D., from New York University Grossman School |
HealthDay
07 August at 11.01 PM
Nipocalimab Can Delay, Prevent Anemia, Intrauterine TransfusionFor pregnancies at high risk for early-onset severe hemolytic disease of the fetus and newborn (HDFN), intravenous nipocalimab can delay or prevent fetal anemia or intrauterine transfusions, according to a study published online Aug. 7 in the New England Journal of Medicine.Kenneth J. Moise Jr., M.D., from Dell Medical School at the U |
HealthDay
07 August at 10.55 PM
FDA Approves Darzalex Faspro for Treating Multiple MyelomaThe U.S. Food and Drug Administration has approved Darzalex Faspro (daratumumab and hyaluronidase-fihj) in combination with bortezomib, lenalidomide, and dexamethasone (D-VRd) for induction and consolidation in patients with newly diagnosed multiple myeloma (MM) who are eligible for an autologous stem cell transplant (ASCT).The approval was ba |
HealthDay
07 August at 03.26 PM
Pharmacogenomic Score Can Personalize Treatment of Leukemia in ChildrenFor pediatric patients with acute myeloid leukemia (AML), a pharmacogenomics-based 10 single nucleotide polymorphism cytarabine (Ara-C) score (ACS10) can be used to tailor induction regimens, yielding improved outcomes, according to a study published online July 30 in Clinical Cancer Research.Noting that low ACS10 has been shown to be |
HealthDay
06 August at 11.08 PM
Many U.S. Adults Lost Trust in Physicians, Hospitals During PandemicU.S. adults lost trust in physicians and hospitals during the COVID-19 pandemic, according to a study published online July 31 in JAMA Network Open.Roy H. Perlis, M.D., from Massachusetts General Hospital in Boston, and colleagues examined how trust in physicians and hospitals changed during the COVID-19 pandemic. The analysis incl |
HealthDay
06 August at 11.01 PM
FDA Approves Tecelra as First Gene Therapy for Synovial SarcomaThe U.S. Food and Drug Administration has approved Tecelra (afamitresgene autoleucel), a gene therapy for the treatment of adults with unresectable or metastatic synovial sarcoma.Specifically, the approval is for adults who have received prior chemotherapy, are HLA-A*02:01P, -A*02:02P, -A*02:03P, or -A*02:06P positive, and have a tumor that expr |
HealthDay
06 August at 03.47 PM
Aspirin-Linked Reduction in CRC Risk Varies With Lifestyle ScoreAspirin use is associated with a reduction in colorectal cancer (CRC) risk, with the greatest reduction seen among those with the unhealthiest lifestyle scores, according to a study published online Aug. 1 in JAMA Oncology.Daniel R. Sikavi, M.D., from Massachusetts General Hospital and Harvard Medical School in Boston, and colleagues ex |
HealthDay
05 August at 04.10 PM
Potentially Hepatotoxic Botanicals Frequently Used in United StatesAn estimated 15 million U.S. adults consumed at least one of six potentially hepatotoxic botanicals within the previous 30 days, according to a study published online Aug. 5 in JAMA Network Open.Alisa Likhitsup, M.D., M.P.H., from the University of Michigan in Ann Arbor, and colleagues assessed the prevalence and clinical characteristics |
HealthDay
05 August at 04.03 PM
2021 to 2023 Saw Considerable Increase in Semaglutide FillsFrom 2021 through 2023, there was a considerable increase in the number of semaglutide fills, according to a research letter published online Aug. 2 in JAMA Health Forum.Christopher Scannell, M.D., Ph.D., from the University of Southern California in Los Angeles, and colleagues analyzed trends in prescriptions dispensed at retail pharmac |
HealthDay
05 August at 03.44 PM
Monitoring Important With Antidepressants for Alcohol Use DisorderFor patients with alcohol use disorder (AUD) treated with antidepressants, those who achieve a reduction in depression symptoms have fewer relapses over time, according to a study published online July 26 in Alcohol: Clinical & Experimental Research.Joshua Jaeger, from the University of Bern in Switzerland, and colleagues examined th |
HealthDay
05 August at 03.37 PM
Oversight of DOAC Prescribing Beneficial for A-Fib, VTE PatientsDirect oral anticoagulant (DOAC) prescribing oversight for off-label prescribing is beneficial while patients are prescribed DOAC, according to a study published online July 30 in Thrombosis and Haemostasis.Grace C. Herron, from the Frankel Cardiovascular Center at the University of Michigan in Ann Arbor, and colleagues evaluated data fr |
HealthDay
02 August at 11.01 PM
Availability Increased With Approval of Naloxone as OTC MedicationRecently, there was an increase in availability of naloxone after it was approved to be sold as an over-the-counter (OTC) medication, according to a study published online July 26 in JAMA Health Forum.Grace T. Marley, Pharm.D., from the UNC Eshelman School of Pharmacy in Chapel Hill, North Carolina, and colleagues examined whether the ac |
HealthDay
02 August at 10.52 PM
FDA Approves Leqselvi for Severe AlopeciaThe U.S. Food and Drug Administration has approved Leqselvi (deuruxolitinib) tablets for the treatment of adults with severe alopecia areata.Leqselvi (8 mg) is a twice-daily oral selective inhibitor of the Janus kinases JAK1 and JAK2. In trials, the three most common adverse events were headache, acne, and nasopharyngitis.The approval was |
HealthDay
02 August at 04.03 PM
Semaglutide Products Being Sold Online Without PrescriptionsSemaglutide products are being sold online, with products likely unregistered or unlicensed, according to a research letter published online Aug. 2 in JAMA Network Open.Amir Reza Ashraf, Pharm.D., from the University of Pécs in Hungary, and colleagues conducted a risk assessment of semaglutide online sourcing. Websites advertising semagl |
HealthDay
01 August at 04.02 PM
Pharmacist Prescribing Can Reduce Stroke Risk in A-Fib PatientsCommunity pharmacists can play an effective role in closing gaps in the delivery of stroke risk reduction therapy by prescribing appropriate oral anticoagulation therapy (OAC) for high-risk older individuals with atrial fibrillation (AF), according to a study published online July 24 in JAMA Network Open.Roopinder K. Sandhu, M.D. |
HealthDay
01 August at 03.47 PM
COVID-19 Vaccination May Increase Risk for Urinary Tract SymptomsCOVID-19 vaccination seems to have some side effects on the lower urinary tract and overactive bladder in younger adults, according to a study published online June 24 in Frontiers in Medicine.Marta de-la-Plaza-San-Frutos, from Universidad Europea de Madrid in Spain, and colleagues examined potential side effects of COVID-19 vaccinatio |
HealthDay
31 July at 03.53 PM
Cholesterol Absorption Inhibitors May Cut Risk for Liver CancerThe use of cholesterol absorption inhibitors is associated with a reduced risk for liver cancer, according to a study published online July 29 in Cancer.Shahriar A. Zamani, Ph.D., from the National Cancer Institute at the National Institutes of Health in Rockville, Maryland, and colleagues examined the risk for liver cancer for |
HealthDay
31 July at 03.35 PM
Methotrexate Beneficial for Reducing Pain, Stiffness in Knee OsteoarthritisFor patients with knee osteoarthritis (KOA), methotrexate added to usual medication is associated with a significant reduction in pain and improvement in stiffness and function at six months, according to a study published online July 30 in the Annals of Internal Medicine.Sarah R. Kingsbury, Ph.D., from the University of Leeds in the |
HealthDay
30 July at 03.43 PM
Toxicities Rare After Two Weeks of CAR T-Cell Therapy InfusionNew-onset cytokine release syndrome (CRS) and immune effector cell-associated neurotoxicity syndrome (ICANS) are rare beyond two weeks following infusion of CD19-directed chimeric antigen receptor T (CAR T)-cell therapies, according to a study published online July 23 in Blood Advances.Noting that the U.S. Food and Drug Administration |
HealthDay
30 July at 03.37 PM
Study Looks at Opioid Dispensing Among Youths Undergoing SurgeryOverall, 16.2 percent of opioid-naive youths undergoing a surgical procedure filled an initial opioid prescription one to 14 days before surgery, according to a study published online July 5 in JAMA Network Open.Tori N. Sutherland, M.D., M.P.H., from the Children's Hospital of Philadelphia, and colleagues characterized changes in preop |
HealthDay
30 July at 03.32 PM
Nasal Sprays, Behavioral Intervention Aid in Treatment of Respiratory IllnessUse of nasal sprays and a behavioral intervention promoting physical activity and stress management can reduce antibiotic use for respiratory illness, according to a study published online July 11 in The Lancet Respiratory Medicine.Paul Little, M.B.B.S., M.D., from the University of Southampton in the United Kingdom, and colleagues exa |
HealthDay
30 July at 03.26 PM
Once-Daily TAS-303 Superior to Placebo for Stress Urinary IncontinenceOnce-daily TAS-303 is superior to placebo for treatment of stress urinary incontinence (SUI) in women, according to a study published in the August issue of The Journal of Urology.Satoru Takahashi, M.D., Ph.D., from Nihon University School of Medicine in Tokyo, and colleagues conducted a double-blind phase 2 study involving women with |
HealthDay
30 July at 09.57 AM
FDA Warns of Accidental Overdoses From Compounded Versions of OzempicPeople taking compounded versions of Ozempic have been overdosing on the drug, the U.S. Food and Drug Administration warns.These ODs typically are due to miscommunications or miscalculations regarding dosage, the FDA added.“Dosing errors have res |
HealthDay
29 July at 09.30 PM
Semaglutide Seems Beneficial for Comorbid T2DM, Tobacco Use DisorderFor patients with type 2 diabetes mellitus (T2DM) and tobacco use disorder (TUD), new use of semaglutide is associated with lower risk of TUD-related health care measures compared with other antidiabetes medications, according to a study published online July 30 in the Annals of Internal Medicine.William Wang, from the Case Western Rese |
HealthDay
29 July at 03.30 PM
Blinatumomab + Chemo Ups Survival in B-Cell Precursor Acute Lymphoblastic LeukemiaFor adult patients with B-cell precursor acute lymphoblastic leukemia (BCP-ALL) who have measurable residual disease (MRD)-negative remission, blinatumomab in addition to consolidation chemotherapy is associated with improved overall survival, according to a study published in the July 25 issue of the New England Journal of Medicine.Mar |
HealthDay
29 July at 03.30 PM
Long-Acting Early Viral Inhibition Described in Context of Long-Acting Injectable CabotegravirIn a research letter published online July 24 in the New England Journal of Medicine, the authors describe long-acting early viral inhibition (LEVI) among patients with acute HIV infection in the context of long-acting injectable cabotegravir (CAB-LA) preexposure prophylaxis (PrEP). The research was published to coincide with the 25th Internat |
HealthDay
26 July at 03.50 PM
Hydroxychloroquine Safe, Effective Treatment for Anogenital Lichen SclerosusHydroxychloroquine appears to be a safe and effective treatment option for anogenital lichen sclerosus that only has mild adverse effects, according to a study published online July 19 in the International Journal of Dermatology.Christeebella O. Akpala, from the Mayo Clinic in Rochester, Minnesota, and colleagues analyzed the demog |
HealthDay
26 July at 10.45 AM
Certain Abbott Blood Sugar Monitors May Give Incorrect ReadingsAbbott has warned diabetes patients that some of its continuous blood sugar monitoring systems may need to be replaced because of inaccurate readings."Abbott has recently identified a small number of FreeStyle Libre 3 sensors that may provide incorrect high glucose readings, which if undetected may pose a potential health risk for people living |
HealthDay
26 July at 10.12 AM
Fake Oxycontin Pills Widespread and Potentially Deadly: ReportThe rate at which young Americans are ending up in hospital ICUs after using fake Oxycontin pills spiked with fentanyl is soaring, especially in the U.S. West, a new report warns.Medical toxicology data from one unnamed hospital in the western U.S. found the number of cases involving overdoses involving fake "M-30" Oxycontin pills rose from just |
HealthDay
25 July at 06.45 PM
Declines Seen in Medical, Nonmedical Use of Prescription Meds Among TeensU.S adolescents reported declines in medical use and nonmedical use (NMU) of prescription stimulants, opioids, and benzodiazepines from 2009 to 2022, according to a research letter published online July 24 in the Journal of the American Medical Association.Sean Esteban McCabe, Ph.D., from the University of Michigan School of Nursing i |
HealthDay
25 July at 03.23 PM
Exposure to Hydroxyurea Does Not Impact Ovarian Reserve in Sickle CellFor girls and young women with sickle cell disease (SCD), exposure to hydroxyurea does not reduce ovarian reserve, according to a study published online July 18 in Blood Advances.Tamara Diesch-Furlanetto, Ph.D., from the University of Basel Children's Hospital in Switzerland, and colleagues counted follicles and categorized them based |
HealthDay
24 July at 03.24 PM
Lack of Institutional Support May Drive Physician Reluctance to Address AddictionLack of institutional support is the most common reason for physicians to have reluctance to address substance use and addiction in their clinical practices, according to a review published online July 17 in JAMA Network Open.Melinda Campopiano von Klimo, M.D., from JBS International Inc. in North Bethesda, Maryland, and colleag |
HealthDay
24 July at 03.23 PM
Adverse Event Risk Up for >90 Days Versus >30 Days of Corticosteroids for EczemaUse of oral corticosteroids for >90 days during one year is associated with a slightly increased risk of adverse events (AEs), according to a study published online July 19 in JAMA Network Open.Yong Hyun Jang, M.D., Ph.D., from Kyungpook National University in Daegu, South Korea, and colleagues examined the association betwee |
HealthDay
23 July at 10.27 PM
Long-Term Sulfonylurea Use Tied to Impaired Awareness of HypoglycemiaThe prevalence of impaired awareness of hypoglycemia (IAH) is high among patients using sulfonylureas long term, according to a study published in the July/August issue of the Annals of Family Medicine.Hsiang-Ju Cheng, M.D., from the National Cheng Kung University in Tainan, Taiwan, and colleagues investigated the relationship bet |
HealthDay
23 July at 03.50 PM
Digoxin, Beta-Blockers Have Equivalent Effects on Heart Rate in A-FibFor patients with atrial fibrillation, digoxin and beta-blockers have equivalent effects on heart rate at rest and on exertion, according to a study published online July 15 in Nature Medicine.Simrat K. Gill, from the University of Birmingham in the United Kingdom, and colleagues compared heart rate in older, multimorbid patients with |
HealthDay
23 July at 03.45 PM
Long COVID Incidence Declined Over Course of PandemicThe cumulative incidence of postacute sequelae of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection (PASC) during the first year after infection decreased over the course of the pandemic, according to a study published online July 17 in the New England Journal of Medicine.Yan Xie, Ph.D., from the Veterans Affa |
HealthDay
22 July at 09.49 PM
2011 to 2023 Saw Increase in New GLP-1 Receptor Agonist PrescriptionsFrom 2011 to 2023, there was an increase in new glucagon like peptide 1 receptor agonist (GLP-1RA) prescriptions, according to a research letter published online July 23 in the Annals of Internal Medicine.Yee Hui Yeo, M.D., from Cedars-Sinai Medical Center in Los Angeles, and colleagues examined nationwide trends in GLP-1RA prescription |
HealthDay
22 July at 09.48 PM
Study Looks at Co-Use of CYP2D6-Metabolizing Opioids, Antidepressants in SeniorsFor older nursing home (NH) residents, use of CYP2D6-metabolized opioids concomitantly with CYP2D6-inhibiting antidepressants is associated with worsening pain and increased risk of opioid-related adverse events (ORAEs), according to a study published online July 23 in the Annals of Internal Medicine.Yu-Jung Jenny Wei, Ph.D., from the C |
HealthDay
22 July at 03.15 PM
Neuromuscular Training Cuts Onset of Chemo-Induced Peripheral NeuropathyNeuromuscular training reduces the onset of chemotherapy-induced peripheral neuropathy (CIPN), according to a study published online July 1 in JAMA Internal Medicine.Fiona Streckmann, Ph.D., from the University of Basel in Switzerland, and colleagues examined whether sensorimotor training (SMT) and whole-body vibration (WBV) training re |
HealthDay
19 July at 04.13 PM
Efanesoctocog Alfa Prophylaxis Beneficial for Children With Hemophilia AFor children with severe hemophilia A, once-weekly prophylaxis with efanesoctocog alfa is associated with high sustained factor VIII activity, resulting in effective prevention of bleeding, according to a study published in the July 18 issue of the New England Journal of Medicine.Lynn Malec, M.D., from the Versiti Blood Research Institu |
HealthDay
19 July at 03.54 PM
Micronutrient Supplementation Slows Geographic Atrophy ProgressionOral micronutrient supplementation slows geographic atrophy (GA) progression in age-related macular degeneration (AMD), according to a study published online July 16 in Ophthalmology.Tiarnan D.L. Keenan, B.M., B.Ch., Ph.D., from the National Institutes of Health in Bethesda, Maryland, and colleagues examined whether oral supplements slo |
HealthDay
19 July at 03.51 PM
COVID-19 Infection, Vaccination Not Linked to Congenital AnomaliesCOVID-19 infection and vaccination during the first trimester of pregnancy are not associated with congenital anomalies, according to a study published online July 17 in The BMJ.Maria C. Magnus, Ph.D., from the Norwegian Institute of Public Health in Oslo, and colleagues conducted a prospective cohort study of 343,066 live-born singleto |
HealthDay
18 July at 04.04 PM
Postexposure Prophylaxis With Nirmatrelvir-Ritonavir Does Not Cut COVID-19 InfectionPostexposure prophylaxis with nirmatrelvir-ritonavir for five or 10 days does not reduce the risk for symptomatic severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, according to a study published in the July 18 issue of the New England Journal of Medicine.Jennifer Hammond, Ph.D., from Pfizer in Collegeville, Penns |
HealthDay
17 July at 10.29 PM
Risankizumab Noninferior, Superior to Ustekinumab for Crohn DiseaseFor patients with moderate-to-severe Crohn disease, risankizumab is noninferior to ustekinumab for clinical remission at week 24 and is superior for endoscopic remission at week 48, according to a study published in the July 18 issue of the New England Journal of Medicine.Laurent Peyrin-Biroulet, M.D., Ph.D., from the INFINY Institut |
HealthDay
17 July at 10.27 PM
Ofatumumab Effective for MS Across Racial, Ethnic SubgroupsFor patients with relapsing multiple sclerosis (RMS), ofatumumab is more effective than teriflunomide across racial and ethnic subgroups, according to a study published online July 17 in Neurology.Mitzi J. Williams, M.D., from the Joi Life Wellness MS Center in Atlanta, and colleagues conducted a post-hoc analysis to compare the prop |
HealthDay
17 July at 03.29 PM
Extended-Release Oral Ketamine Effective for Treatment-Resistant DepressionFor patients with treatment-resistant depression, racemic ketamine, given as an extended-release tablet (R-107), administered orally, is effective, safe, and well tolerated, according to a study published online June 24 in Nature Medicine.Paul Glue, M.D., from the University of Otago in Dunedin, New Zealand, and colleagues examined t |
HealthDay
17 July at 03.14 PM
Aging Into Medicare Tied to Higher Drug Costs for People With DiabetesAs people with diabetes age into Medicare, they face increased quarterly out-of-pocket costs for medication, according to a study published online July 9 in JAMA Network Open.Douglas Barthold, Ph.D., from the University of Washington in Seattle, and colleagues examined whether reaching age 65 years is associated with changes in |
HealthDay
16 July at 10.52 PM
Direct CGRP Inhibition Cuts Acne, Rosacea in Patients With MigraineFor patients experiencing migraine, direct calcitonin gene-related peptide (CGRP) inhibition with monoclonal antibodies (mAbs) is associated with reduced rates of acne and rosacea compared with no inhibition (topiramate) or indirect inhibition (triptans), according to a research letter published online July 10 in JAMA Dermatology.Chris |
HealthDay
16 July at 03.47 PM
Benzodiazepines Not Tied to Higher Dementia Risk in Older AdultsUse of benzodiazepines is not associated with increased dementia risk in older adults, according to a study published online July 2 in BMC Medicine.Ilse vom Hofe, from Erasmus University Medical Center in the Netherlands, and colleagues examined long-term effects of benzodiazepines (anxiolytics or sedative-hypnotics) on neurodegen |
HealthDay
16 July at 03.40 PM
Self-Imposed Use Cessation Dates Tied to Ophthalmic Drop WasteSelf-imposed use cessation dates (SUCD) for multiuse eye drop bottles leads to significant drug waste and associated costs, according to a report published online July 1 in Ophthalmology.John M. Tan, from the Icahn School of Medicine at Mount Sinai in New York City, and colleagues quantified the volume of drugs discarded in ambula |
HealthDay
16 July at 03.29 PM
Suicidal Ideation, Behaviors Not Increased With GLP-1 RAs for Seniors With T2DFor older adults with type 2 diabetes (T2D), use of glucagon-like peptide 1 receptor agonists (GLP-1 RAs) is not associated with a significantly increased risk for suicidal ideation and behaviors, according to a study published online July 16 in the Annals of Internal Medicine.Huilin Tang, from the University of Florida College of Phar |
HealthDay
15 July at 10.00 PM
Metformin, SGLT2 Inhibitors Exhibit Significantly Lower Dementia RiskCompared with other antidiabetic classes, metformin and sodium glucose co-transporter-2 inhibitors (SGLT2is) exhibit significantly lower dementia risk, according to a review published online May 3 in the American Journal of Preventive Medicine.Yongjun Sunwoo, from the College of Pharmacy at Kyung Hee University in Seoul, South Korea, an |
HealthDay
15 July at 03.23 PM
Low Quantity of Opioids Used After ED Discharge for Acute PainFor patients presenting with acute pain, the quantity of opioids consumed during two weeks after emergency department discharge is low and varies across pain conditions, according to a study published online July 15 in CMAJ, the journal of the Canadian Medical Association.Raoul Daoust, M.D., from Sacré-Coeur Hospital in Montreal, and co |
HealthDay
15 July at 12.36 PM
Global Childhood Vaccination Rates Still Haven't Recovered from Pandemic DeclinesMore than four years after the pandemic began, childhood vaccination rates worldwide have yet to recover, a new report shows.The latest data, issued Monday by the World Health Organization and the United Nations International Children’s Emergency Fund (UNICEF), underscore the need for continuing to try to catch-up to pre-pandemic levels.“ |
HealthDay
12 July at 10.23 PM
CDC Reports Seven Cases of Illness After Possible Counterfeit Botox InjectionsSeven patients with illness identified after presumed cosmetic botulinum neurotoxin (BoNT) product injection are described in a case report published in the July 11 issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report.Christine M. Thomas, D.O., from the CDC in Atlanta, and colleagues charact |
HealthDay
12 July at 10.21 PM
More Women Than Men Experience Nonphysical Violence in Health Care WorkforceWomen in the health care workforce are more likely to experience verbal abuse, sexual harassment, and bullying, while men are more likely to experience physical violence, according to a study published online July 2 in PLOS Global Public Health.Sioban Nelson, R.N., Ph.D., from the University of Toronto, and colleagues conducted a scopin |
HealthDay
12 July at 10.16 PM
Only One-Quarter of Patients Still Taking Semaglutide for Weight Loss Two Years LaterThree of four patients stop taking semaglutide (Ozempic or Wegovy) two years after being prescribed the glucagon-like peptide-1 receptor agonist (GLP-1 RA) for weight loss, according to new analysis conducted by Prime Therapeutics and Magellan Rx Management (MRx).For the review, pharmacy and medical claims data for 3,364 people with insurance pl |
HealthDay
12 July at 03.43 PM
More Than Half Do Not Know Primary Care Providers Can Treat Opioid Use DisorderMany people do not know that a primary care provider (PCP) can provide medication for opioid use disorder (MOUD), according to a research letter published online June 28 in JAMA Network Open.Brandon del Pozo, Ph.D., from the Brown University School of Public Health in Providence, Rhode Island, and colleagues surveyed 1,234 individu |
HealthDay
12 July at 03.38 PM
Prenatal Vaccination With RSV Prefusion F Does Not Increase Risk for Preterm BirthPrenatal vaccination with a nonadjuvanted bivalent respiratory syncytial virus (RSV) prefusion F (RSVpreF) protein subunit vaccine is not associated with an increased risk for preterm birth (PTB), according to a study published online July 8 in JAMA Network Open.In a retrospective observational cohort study, Moeun Son, M.D., from the We |
HealthDay
11 July at 10.11 PM
FDA Approves Zoryve for Atopic DermatitisThe U.S. Food and Drug Administration has approved Zoryve (roflumilast) cream, 0.15 percent, for the treatment of mild-to-moderate atopic dermatitis in adult and pediatric patients (ages 6 years and older).Zoryve is a once-daily, steroid-free cream that the company says will be available at the end of July.The approval was based on resu |
HealthDay
11 July at 04.04 PM
GLP-1 RAs May Reduce Risk for Some Obesity-Linked Cancers Versus Insulin in T2DFor patients with type 2 diabetes (T2D), glucagon-like peptide 1 receptor agonists (GLP-1 RAs) are associated with a reduced risk for 10 of 13 obesity-associated cancers (OACs) compared with insulin, according to a study published online July 5 in JAMA Network Open.Lindsey Wang, from Case Western Reserve University School of Medicine |
HealthDay
11 July at 03.45 PM
First-Trimester COVID-19 Vaccine Does Not Increase Risk for Birth DefectsFirst-trimester mRNA COVID-19 vaccine exposure is not associated with an increased risk for selected major structural birth defects, according to a study published online July 1 in JAMA Pediatrics.Elyse O. Kharbanda, M.D., M.P.H., from HealthPartners Institute in Minneapolis, and colleagues assessed whether receipt of an mRNA COV |
HealthDay
10 July at 10.23 PM
Nirsevimab Effective Against RSV-Linked Bronchiolitis HospitalizationNirsevimab therapy is effective for reducing the risk for hospitalization for respiratory syncytial virus (RSV)-associated bronchiolitis among infants, according to a study published in the July 11 issue of the New England Journal of Medicine.Zein Assad, M.D., from the Robert Debré University Hospital in Paris, and colleagues conduct |
HealthDay
10 July at 03.58 PM
Study Looks at Impact of Incentivizing Smoking Cessation in Addition to Usual CareIncentivizing smoking cessation increases smoking cessation through 12 weeks, but not at 26 weeks, when missing data are treated as smoking, according to a study published online July 2 in JAMA Network Open.Darla E. Kendzor, Ph.D., from the University of Oklahoma Health Sciences Center in Oklahoma City, and colleagues randomly assign |
HealthDay
10 July at 03.12 PM
Most Children With Conjunctivitis Have Rx for Topical Antibiotics FilledMore than two-thirds of children with conjunctivitis have a prescription filled for topical antibiotics within one day of an ambulatory care visit, according to a research letter published online June 27 in JAMA Ophthalmology.Daniel J. Shapiro, M.D., M.P.H., from the University of California, San Francisco, and colleagues examined pr |
HealthDay
09 July at 03.32 PM
1999 to Mid-2000s Saw Increase in Seniors Using Prescription MedsFrom 1999 to the mid-2000s, the proportion of U.S. adults aged 65 years or older who used prescription medications increased, according to a research letter published online July 1 in JAMA Internal Medicine.Gabriel K. Innes, V.M.D., Ph.D., from the U.S. Food and Drug Administration in Silver Spring, Maryland, and colleagues analyzed dat |
HealthDay
09 July at 12.41 PM
More Americans Now Think Abortion Should Be Allowed in Any CircumstanceTwo years after the U.S. Supreme Court overturned Roe v. Wade, more Americans think their state should allow a woman to get a legal abortion for any reason, a new poll finds.Just over 6 in 10 of those questioned say women should have that right, compared to just under 50% of Americans who held the same belief in 2021, the new <a href="https://ap |
HealthDay
08 July at 09.38 PM
Significantly More Weight Loss Seen With Tirzepatide Versus SemaglutideTirzepatide is associated with significantly greater weight loss than semaglutide for adults with overweight or obesity, according to a study published online July 8 in JAMA Internal Medicine.Patricia J. Rodriguez, Ph.D., from Truveta Inc. in Bellevue, Washington, and colleagues compared on-treatment weight loss and rates of gastrointest |
HealthDay
08 July at 09.36 PM
Acupuncture Can Reduce Methadone Dose, Opioid CravingFor individuals with opioid use disorder receiving methadone maintenance treatment (MMT), eight weeks of acupuncture is superior to sham acupuncture for reducing methadone dose and opioid craving, according to a study published online July 9 in the Annals of Internal Medicine.Liming Lu, M.D., from the Guangzhou University of Chinese Medi |
HealthDay
08 July at 09.33 PM
Study Compares Rivaroxaban, Warfarin With Apixaban for Cirrhosis, A-FibFor patients with cirrhosis and nonvalvular atrial fibrillation (AF), initiators of rivaroxaban or warfarin versus apixaban have significantly higher rates of major hemorrhage, according to a study published online July 9 in the Annals of Internal Medicine.Tracey G. Simon, M.D., M.P.H., from Brigham and Women's Hospital in Boston, and co |
HealthDay
08 July at 03.26 PM
Tisotumab Vedotin Efficacious for Recurrent Cervical CancerSecond- or third-line treatment with tisotumab vedotin is efficacious for patients with recurrent cervical cancer, according to a study published in the July 4 issue of the New England Journal of Medicine.Ignace Vergote, M.D., Ph.D., from Universitaire Ziekenhuizen Leuven in Belgium, and colleagues conducted a phase 3, multinational, ope |
HealthDay
08 July at 03.17 PM
ACEi, ARB Use Linked to Lower Risk for Kidney Failure With Replacement TherapyFor individuals with advanced chronic kidney disease (CKD), angiotensin-converting enzyme inhibitor (ACEi) or angiotensin-receptor blocker (ARB) treatment is associated with a reduced risk for kidney failure with replacement therapy (KFRT) but not death, according to a study published online July 2 in the Annals of Internal Medicine.Elai |
HealthDay
08 July at 02.56 PM
Study Looks at Abortion Rates With No-Test Telehealth Screening, Meds MailingAccess to medication abortion using history-based (no-test) eligibility assessment, including through telehealth, and mailing of mifepristone lead to similar rates of complete abortion as in-person care with ultrasonography, according to a study published online June 24 in the Journal of the American Medical Association.Lauren J. Ralph, |
HealthDay
08 July at 02.52 PM
Granting Waiver for Cancer Treatment Does Not Affect Safety, Efficacy OutcomesIn a trial involving patients with therapy-refractory cancer treated with approved targeted or immunotherapies, matched to their tumor molecular profile but outside their registered indications, those for whom a waiver was granted had similar serious adverse event rates and clinical benefit rates as those who did not receive a waiver, according to a stu |
HealthDay
03 July at 08.32 PM
Semaglutide Linked to Nonarteritic Anterior Ischemic Optic NeuropathySemaglutide is associated with nonarteritic anterior ischemic optic neuropathy (NAION) among patients with type 2 diabetes (T2D) and those with overweight/obesity, according to a study published online July 3 in JAMA Ophthalmology.Jimena Tatiana Hathaway, M.D., M.P.H., from the Harvard T.H. Chan School of Public Health in Boston, and |
HealthDay
03 July at 03.07 PM
Higher COVID-19 Vaccination Rates Tied to Decrease in Childhood Asthma SymptomsHigher COVID-19 vaccination rates are associated with a lower prevalence of parent-reported childhood asthma symptoms, according to a research letter published online July 3 in JAMA Network Open.Matthew M. Davis, M.D., from Nemours Children's Health in Wilmington, Delaware, and Lakshmi K. Halasyamani, M.D., from Endeavor Health in Eva |
HealthDay
03 July at 02.50 PM
Many Teen Girls Seeking Care in the ED at High Risk for PregnancySexually active adolescents seeking care in the emergency department have a high risk for pregnancy, and the emergency department may provide a feasible environment to offer contraception counseling, according to a study published online June 28 in JAMA Network Open.Hannah Canter, M.D., from Oregon Health and Science University i |
HealthDay
02 July at 07.33 PM
FDA Approves New Drug to Treat Alzheimer'sA new drug to treat Alzheimer's disease was approved by the U.S. Food and Drug Administration on Tuesday.In clinical trials, donanemab (Kisunla) modestly slowed the pace of thinking declines among patients in the early stages of the m |
HealthDay
02 July at 05.05 PM
U.S. Government to Pay Moderna $176 Million to Develop mRNA Flu VaccineU.S. health officials announced Tuesday that the federal government will pay Moderna $176 million to speed development of a pandemic flu vaccine based on mRNA technology.Such a vaccine could be used to treat bird flu in people, as concern grows about H5N1 cases spreading in dairy cows across the country, the U.S. Department of Health a |
HealthDay
02 July at 04.01 PM
Mean Cost of Bringing New Drug to U.S. Market Is $879.3 MillionThe mean cost of developing a new drug for the U.S. market is estimated to be $879.3 million when both drug development failure and capital costs are considered, according to a study published online June 28 in JAMA Network Open.Aylin Sertkaya, Ph.D., from Eastern Research Group Inc., in Lexington, Massachusetts, and colleagues ass |
HealthDay
01 July at 10.10 PM
Small Differences in Weight Change With First-Line AntidepressantsFor eight first-line antidepressants, small differences are seen in mean weight change, with the least weight gain with bupropion, according to a study published online July 2 in the Annals of Internal Medicine.Joshua Petimar, Sc.D., from Harvard Medical School and Harvard Pilgrim Health Care Institute in Boston, and colleagues conducted |
HealthDay
01 July at 03.22 PM
Amivantamab-Lazertinib Ups Survival in EGFR-Mutated Advanced Lung CancerFor patients with EGFR-mutated advanced non-small cell lung cancer (NSCLC), amivantamab-lazertinib yields improved progression-free survival compared with osimertinib as first-line treatment, according to a study published online June 26 in the New England Journal of Medicine.Byoung C. Cho, M.D., Ph.D., from the Yonsei Cancer Ce |
HealthDay
28 June at 10.09 PM
NCCN: Cancer Drug Shortages Remain a Challenge for CliniciansAlmost 90 percent of medical centers report cancer drug shortages, which often impact clinical trials, according to the results of a National Comprehensive Cancer Network survey.Following data published one year ago and six months ago illustrating shortages of crucial cancer drugs, the National Comprehensive Cancer Network published new results |
HealthDay
28 June at 09.54 PM
Small Number of Procedures Account for Large Number of Opioid PrescriptionsA small number of surgical procedures, including orthopedic procedures and cesarean delivery, account for a large proportion of opioid prescriptions dispensed after surgery, according to a study published online June 26 in JAMA Network Open.Dominic Alessio-Bilowus, from Michigan Medicine in Ann Arbor, and colleagues examined the surgica |
HealthDay
28 June at 03.02 PM
Clinical Response Seen for Patients With Severe Asthma Initiating BiologicsPatients with severe asthma initiating biologics exhibit clinical responses and super-responses, but 40 to 50 percent do not meet response criteria, according to a study published online June 22 in Allergy.Eve Denton, M.B.B.S., from Alfred Health in Melbourne, Australia, and colleagues examined responsiveness to biologics in a real-worl |
HealthDay
28 June at 03.01 PM
Guidelines Address RT for Management of HPV-Linked Oropharyngeal CancerIn a clinical practice guideline issued by the American Society for Radiation Oncology and published online June 18 in Practical Radiation Oncology, recommendations are presented for the use of radiation therapy (RT) for management of human papillomavirus (HPV)-associated oropharyngeal squamous cell carcinoma (OPSCC).Danielle N. Margali |
HealthDay
28 June at 02.12 PM
Supreme Court Rejects Purdue Pharma Opioid SettlementThe U.S. Supreme Court on Thursday struck down a controversial settlement that drug maker Purdue Pharma had reached with victims of the opioid epidemic.The ruling threatens a massive bankruptcy plan that would have protected the Sackler family, which controls the compan |
HealthDay
28 June at 11.51 AM
CDC Advises Updated COVID Vaccine for Everyone Over 6 Months of AgeAs a summer wave of COVID infections rolls across the country, U.S. health officials have recommended that all Americans over the age of 6 months get one of the updated COVID vaccines when they become available this fall.The recommendation was issued Thurs |
HealthDay
27 June at 09.36 PM
Only One-Quarter of Adults Who Needed Opioid Use Disorder Meds in 2022 Received ThemOnly one-quarter of adults who needed opioid use disorder (OUD) treatment in 2022 received medications for OUD, according to research published in the June 27 issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report.Deborah Dowell, M.D., from the CDC in Atlanta, and colleagues characterized U. |
HealthDay
27 June at 03.19 PM
Immunoglobulin Replacement Therapy Beneficial for Blood CancersImmunoglobulin replacement therapy (IgRT) is associated with reductions in hypogammaglobulinemia, infections, severe infections, and associated antimicrobial use among real-world patients with chronic lymphocytic leukemia (CLL) or non-Hodgkin lymphoma (NHL), according to a study published online June 21 in Blood Advances.Jacob D. Soum |
HealthDay
27 June at 03.18 PM
Exercise + GLP-1 RA Effective for Weight Loss While Preserving BMDFor adults with obesity, without diabetes, combining exercise with the glucagon-like peptide-1 receptor agonist (GLP-1 RA), liraglutide, is effective for weight loss, while preserving bone health, according to a study published online June 25 in JAMA Network Open.Simon Birk Kjær Jensen, Ph.D., from the University of Copenhagen in Denm |
HealthDay
27 June at 03.16 PM
ADA: Inhaled Insulin Shows Promise for Adults With Type 1 DiabetesInhaled insulin is associated with improved hemoglobin A1c (HbA1c) levels over 16 weeks among adults with type 1 diabetes when compared to usual care, according to a study presented at the annual meeting of the American Diabetes Association, held from June 21 to 24 in Orlando, Florida.Irl B. Hirsch, M.D., from the University of Washington in S |
HealthDay
27 June at 03.14 PM
Dupilumab Ups Histologic Response for Pediatric Eosinophilic EsophagitisFor children with eosinophilic esophagitis, dupilumab results in a significantly higher percentage of histologic remission, according to a study published in the June 27 issue of the New England Journal of Medicine.Mirna Chehade, M.D., M.P.H., from Icahn School of Medicine at Mount Sinai in New York City, and colleagues randomly assig |
HealthDay
27 June at 03.13 PM
PIK3CA Could Guide Use of COX-2 Inhibitors in Treatment for Colon CancerPIK3CA mutational status may be beneficial for predicting response to addition of the cyclooxygenase 2 (COX-2) inhibitor celecoxib to standard adjuvant chemotherapy in stage III resected colon cancer, according to a study published online June 18 in the Journal of Clinical Oncology.Jonathan A. Nowak, M.D., Ph.D., from Brigham |
HealthDay
27 June at 11.32 AM
CDC Strengthens RSV Vaccine Advice for Those Over 75In new vaccination guidance issued Wednesday, U.S. health officials now recommend that all Americans aged 75 and older get an RSV vaccine before fall arrives.However, those a bit younger -- ages 60 to 74 -- should only seek the shot if they are vulnerable to severe RSV because of chronic medical conditions such as lung or heart disease, or if |
HealthDay
26 June at 09.35 PM
Atogepant Efficacious for Patients With Chronic MigraineFor patients with chronic migraine (CM), with and without medication overuse, atogepant is efficacious, according to a study published online June 27 in Neurology.Peter J. Goadsby, M.D., Ph.D., from King's College London, and colleagues examined the efficacy of atogepant for the preventive treatment of CM in participants with and wit |
HealthDay
26 June at 09.32 PM
Histologic Response Up With Benralizumab for Eosinophilic EsophagitisBenralizumab yields a greater histologic response than placebo for patients with eosinophilic esophagitis, but does not affect dysphagia symptoms, according to a study published in the June 27 issue of the New England Journal of Medicine.Marc E. Rothenberg, M.D., Ph.D., from the Leiden University Medical Center in the Netherlands, an |
HealthDay
26 June at 07.46 PM
Multivitamin Use Not Linked to Mortality Benefit in U.S. AdultsMultivitamin (MV) use is not associated with mortality benefit among U.S. adults, according to a study published online June 26 in JAMA Network Open.Erikka Loftfield, Ph.D., M.P.H., from the National Institutes of Health in Rockville, Maryland, and colleagues estimated the association of MV use with mortality risk, accounting for con |
HealthDay
26 June at 06.03 PM
Glofitamab + GemOx Superior to Rituximab + GemOx for LymphomaGlofitamab (Glofit) plus gemcitabine and oxaliplatin (GemOx) is superior to rituximab (R)-GemOx for relapsed/refractory (R/R) diffuse large B-cell lymphoma (DLBCL), according to a study presented at the annual hybrid congress of the European Hematology Association, held from June 13 to 16 in Madrid.Jeremy Abramson, M.D., from the Massachusett |
HealthDay
26 June at 04.53 PM
Decrease in Oral Contraceptive Fills Seen After Dobbs RulingThe Dobbs v Jackson Women's Health Organization decision, allowing states to strengthen restrictions on abortion access, was associated with declines in prescription fills for oral contraceptives, according to a study published online June 26 in JAMA Network Open.Dima M. Qato, Pharm.D., M.P.H., Ph.D., from the University of |
HealthDay
26 June at 04.05 PM
Pediatric Surgical Opioid Prescribing Concentrated Among a Few ProceduresPediatric surgical opioid prescribing is concentrated among a small number of procedures, especially tonsillectomy and/or adenectomy, according to a study published online June 26 in Pediatrics.Kao-Ping Chua, M.D., Ph.D., from the Institute for Healthcare Policy and Innovation in Ann Arbor, Michigan, and colleagues conducted a cross- |
HealthDay
26 June at 03.26 PM
ADA: Semaglutide Similarly Effective in Men, Women With Obesity-Linked Heart FailureFor patients with obesity-related heart failure with preserved ejection fraction (HFpEF), semaglutide reduces body weight to a greater extent in women but yields similar improvements in heart failure-related symptoms in men and women, according to a study published online June 23 in the Journal of the American College of Cardiology to coinc |
HealthDay
26 June at 03.26 PM
ADA: Tirzepatide Reduces Apnea-Hypopnea Index in Moderate-to-Severe OSATirzepatide reduces the apnea-hypopnea index (AHI) among individuals with moderate-to-severe obstructive sleep apnea and obesity, according to a study published online June 21 in the New England Journal of Medicine to coincide with the annual meeting of the American Diabetes Association, held from June 21 to 24 in Orlando, Florida.At |
HealthDay
25 June at 09.42 PM
Abrocitinib Effective, Tolerated for Prurigo Nodularis, Chronic PruritusFor patients with prurigo nodularis (PN) and chronic pruritus of unknown origin (CPUO), abrocitinib, a Janus kinase 1 inhibitor, is effective and well tolerated, according to a study published online June 5 in JAMA Dermatology.Shawn G. Kwatra, M.D., from the University of Maryland School of Medicine in Baltimore, and colleagues examine |
HealthDay
25 June at 03.06 PM
COVID-19 Vaccination Not Tied to Adverse Pregnancy OutcomesmRNA COVID-19 vaccination during pregnancy is not associated with an increased risk of adverse pregnancy outcomes, according to a study published in the June issue of Obstetrics & Gynecology.Kimberly K. Vesco, M.D., M.P.H., from Kaiser Permanente Center for Health Research in Portland, Oregon, and colleagues evaluated the asso |
HealthDay
25 June at 03.04 PM
ADHD Meds May Help Control Opioid Use Disorder in PregnancyPsychostimulants may help opioid use disorder (OUD) outcomes in pregnant women, according to a study published online June 11 in Nature Mental Health.Kevin Y. Xu, M.D., M.P.H., from the Washington University School of Medicine in St. Louis, and colleagues used U.S. multistate administrative data to examine the risks and benef |
HealthDay
25 June at 03.03 PM
Semaglutide Cuts Incidence, Recurrence of Alcohol Use DisorderSemaglutide may cut incidence and recurrence of alcohol use disorder (AUD) in patients with obesity, according to a study published online May 28 in Nature Communications.William Wang, from Case Western Reserve University in Cleveland, and colleagues used electronic health records of 83,825 patients with obesity to examine associa |
HealthDay
25 June at 03.00 PM
SNP rs13194504 AA Genotype Linked to Severity of Tardive DyskinesiaFor patients with schizophrenia, the single-nucleotide polymorphism (SNP) rs13194504 AA genotype is associated with reduced severity of tardive dyskinesia (TD), but is not associated with occurrence, according to a study recently published in Human Psychopharmacology: Clinical & Experimental.Ruoyu Wang, from the Centre for Addictio |
HealthDay
25 June at 12.15 PM
Summer COVID Cases Are Rising Across AmericaAs scorching summer temperatures drive Americans indoors and millions travel for vacations and family gatherings, COVID infections are again climbing, U.S. health officials warned Monday.In evidence that suggests a COVID summer wave is underway, case counts are most likely increasing in 39 states and aren’t declining anywhere in the c |
HealthDay
24 June at 09.25 PM
Medically Advised Aspirin Use Lower in 2021 Than 2012 to 2017Medically advised aspirin use was lower in 2021 than in 2012 to 2017 among older adults, according to a research letter published online June 25 in the Annals of Internal Medicine.Mohak Gupta, M.D., from the Cleveland Clinic, and colleagues characterized trends in prevalence of aspirin use for CVD prevention among U.S. adults aged 40 ye |
HealthDay
24 June at 09.20 PM
FDA Expands Approval for Duchenne Muscular Dystrophy Gene TherapyThe U.S. Food and Drug Administration has expanded the approval of Elevidys (delandistrogene moxeparvovec-rokl), a gene therapy for the treatment of Duchenne muscular dystrophy (DMD) in individuals ≥4 years with DMD with a confirmed mutation in the DMD gene.Elevidys is a single-dose, intravenous recombinant gene therapy designed to prod |
HealthDay
24 June at 03.23 PM
U.S. Supreme Court Agrees to Hear Case on Medical Care for Transgender YouthThe U.S. Supreme Court announced Monday that it would hear a case on a Tennessee law that bans transgender minors from receiving certain medical treatments in that state.The banned treatments include puberty-blocking drugs or hormonal therapies.It's the |
HealthDay
24 June at 03.02 PM
Nonsignificant Survival Benefit Seen for Dabrafenib, Trametinib in MelanomaFor patients with resected stage III melanoma, adjuvant therapy with dabrafenib plus trametinib is associated with a nonsignificant benefit in terms of overall survival, according to a study published online June 19 in the New England Journal of Medicine.Georgina V. Long, M.D., Ph.D., from the University of Sydney, and colleagues random |
HealthDay
24 June at 11.44 AM
Twice-a-Year Injection Gives Women Full Protection Against HIV, Trial FindsJust two injections a year of a new HIV drug protected young women in Africa from infection with the sexually transmitted disease, new trial results show.In announcing the findings, Gilead Sciences Inc. said its HIV medication lenacapavir demonstrated 100% efficacy as a prev |
HealthDay
21 June at 10.54 PM
FDA Approves KEYTRUDA + Chemo for Primary Advanced, Recurrent Endometrial CarcinomaThe U.S. Food and Drug Administration has approved Keytruda (pembrolizumab) plus chemotherapy as treatment for adult patients with primary advanced or recurrent endometrial carcinoma. This is the third FDA-approved indication for Keytruda in endometrial carcinoma.The approval is for Keytruda, an anti-programmed death receptor-1 (anti-PD-1) |
HealthDay
21 June at 10.51 PM
FDA Approves Capvaxive Pneumococcal 21-Valent Conjugate VaccineThe U.S. Food and Drug Administration has approved the Capvaxive pneumococcal 21-valent conjugate vaccine for the prevention of invasive pneumococcal disease and pneumococcal pneumonia in adults.Capvaxive is specifically designed to help protect adults against the serotypes that cause the majority of invasive pneumococcal disease cases, inc |
HealthDay
21 June at 03.36 PM
Timing of Metformin Important in Metformin-Treated Type 2 DiabetesGlucose lowering by metformin is greater when given before enteral glucose among patients with type 2 diabetes controlled by metformin monotherapy, according to a study recently published in Diabetologia.Cong Xie, Ph.D., from the University of Adelaide in Australia, and colleagues studied 16 participants with type 2 diabetes that was re |
HealthDay
21 June at 03.23 PM
Improved Outcomes Seen With Ibrutinib in Chronic Lymphocytic LeukemiaFirst-line ibrutinib is associated with better outcomes than chemoimmunotherapy among patients with chronic lymphocytic leukemia (CLL), according to a study published online May 13 in Clinical Lymphoma, Myeloma & Leukemia.Nilanjan Ghosh, M.D., Ph.D., from the Levine Cancer Institute in Charlotte, North Carolina, and colleagues condu |
HealthDay
21 June at 03.20 PM
Angiotensin Receptor Blocker Use Linked to Lower Incidence of EpilepsyFor patients with hypertension, angiotensin receptor blockers (ARBs) are associated with a reduced incidence of epilepsy compared with other antihypertensive medications, according to a study published online June 17 in JAMA Neurology.Xuerong Wen, Ph.D., from the University of Rhode Island in Kingston, and colleagues conducted a retrosp |
HealthDay
21 June at 03.06 PM
Fewer Adults Eligible for Statins With PREVENT EquationsUse of the Predicting Risk of Cardiovascular Disease Events (PREVENT) equations reduces the number of adults meeting criteria for primary prevention statin therapy compared with use of the 2013 pooled cohort equations (PCEs), according to a study published online June 10 in JAMA Internal Medicine.Timothy S. Anderson, M.D., from the Univ |
HealthDay
21 June at 11.43 AM
WHO, Lilly Issue Warnings About Fake Weight-Loss DrugsBoth the World Health Organization and Eli Lilly warned Thursday that consumers should avoid fake versions of weight-loss drugs that are circulating in numerous countries.The WHO warning said that the inter |
HealthDay
20 June at 08.47 PM
FDA Approves Augtyro for NTRK-Positive Advanced Solid TumorsThe U.S. Food and Drug Administration has approved Augtyro (repotrectinib), a next-generation tyrosine kinase inhibitor (TKI), for the treatment of patients with neurotrophic tyrosine receptor kinase (NTRK)-positive locally advanced or metastatic solid tumors.Augtyro is approved for adult and pediatric patients (aged 12 years and olde |
HealthDay
20 June at 04.00 PM
ViPOR Results in Durable Remission in Specific Subtypes of LymphomaFor patients with specific subtypes of relapsed or refractory diffuse large B-cell lymphoma (DLBCL), treatment with venetoclax, ibrutinib, prednisone, obinutuzumab, and lenalidomide (ViPOR) yields durable remission, according to a study published in the June 20 issue of the New England Journal of Medicine.Christopher Melani, M.D., fro |
HealthDay
20 June at 03.52 PM
About One-Third of Mental Health Facilities Offer Meds for Opioid AddictionAbout one-third of community outpatient mental health treatment facilities (MHTFs) offer medications for opioid use disorder (MOUD), according to a study published online June 18 in JAMA Network Open.Jonathan Cantor, Ph.D., from RAND in Santa Monica, California, and colleagues quantified the availability of MOUD at community outpatien |
HealthDay
20 June at 03.34 PM
Reteplase Superior to Alteplase Within 4.5 Hours of Ischemic StrokeReteplase is noninferior to alteplase for patients with ischemic stroke within 4.5 hours after symptom onset, according to a study published online June 14 in the New England Journal of Medicine to coincide with the 10th Annual Conference of the Chinese Stroke Association & Tiantan International Stroke Conference 2024, held from June 14 |
HealthDay
19 June at 09.29 PM
Dementia With Lewy Bodies Risk Down With α-1 Adrenergic Receptor AntagonistsMen taking α-1 adrenergic receptor antagonists terazosin, doxazosin, and alfuzosin (Tz/Dz/Az) seem to have a lower risk for dementia with Lewy bodies (DLB), according to a study published online June 19 in Neurology.Alexander Hart, M.D., M.P.H., from the University of Michigan in Ann Arbor, and colleagues used a new-user active compa |
HealthDay
19 June at 03.55 PM
Low-Dose Direct Oral Anticoagulants Tied to More Bleeding EpisodesPatients with atrial fibrillation (AF) on low doses of direct oral anticoagulants (DOACs) have more bleeding episodes than those on standard doses, according to a study published online June 6 in Blood Advances.Gualtiero Palareti, M.D., from Fondazione Arianna Anticoagulazione in Bologna, Italy, and colleagues collected venous b |
HealthDay
19 June at 03.52 PM
Varenicline, Nicotine-Containing E-Cigarettes Help in Quitting SmokingVarenicline and nicotine-containing electronic cigarettes (ECs) are both effective in helping individuals in quitting smoking conventional cigarettes, according to a study published online June 17 in JAMA Internal Medicine.Anna Tuisku, Ph.D., from Lapland Central Hospital in Finland, and colleagues randomly assigned 458 particip |
HealthDay
19 June at 03.48 PM
Nearly One in Four Do Not Recover From COVID-19 by 90 DaysJust under one-quarter of adults with self-reported COVID-19 report they had not recovered by 90 days, according to a study published online June 17 in JAMA Network Open.Elizabeth C. Oelsner, M.D., from the Columbia University Irving Medical Center in New York City, and colleagues used data from 14 ongoing National Institutes of |
HealthDay
18 June at 09.11 PM
Approximately 7 Percent of U.S. Population Uninsured in 2023In 2023, 7.6 percent of the U.S. civilian noninstitutionalized population was uninsured, according to early estimates from the National Health Interview Survey, 2023, released by the National Center for Health Statistics.Robin A. Cohen, Ph.D., from the National Center for Health Statistics in Hyattsville, Maryland, and colleagues used data from |
HealthDay
18 June at 03.49 PM
Trametinib Safe, Effective for Juvenile Myelomonocytic LeukemiaFor children with relapsed or refractory juvenile myelomonocytic leukemia (JMML), trametinib is safe and effective, according to a study published online June 12 in Cancer Discovery.Noting that patients with relapsed or refractory (advanced) JMML have poor outcomes, Elliot Stieglitz, M.D., from the University of California San Francisc |
HealthDay
18 June at 03.46 PM
Multimodal Antiobesity Medications Yield Superior Preoperative Weight LossCombining antiobesity medications enhances preoperative weight loss in individuals with high body mass index (BMI) preparing for metabolic surgery, according to a study presented at the annual meeting of the American Society for Metabolic and Bariatric Surgery, held from June 9 to 13 in San Diego.Michael Kachmar, D.O., from the Pennington Biome |
HealthDay
18 June at 03.44 PM
Lebrikizumab Tied to Sustained Atopic Dermatitis Treatment EffectLebrikizumab is associated with sustained effects for moderate-to-severe atopic dermatitis for up to week 52 following withdrawal of treatment, according to a study presented at the annual Revolutionizing Atopic Dermatitis Conference, held from June 8 to 10 in Chicago.Jonathan I. Silverberg, M.D., Ph.D., M.P.H., from the George Washington Unive |
HealthDay
18 June at 03.32 PM
Continuing Metformin in Pregnancy Has Little Effect on Nonlive BirthContinuing metformin and adding insulin in early pregnancy does not significantly alter the risk for nonlive birth or live birth with congenital malformations compared with switching to insulin monotherapy, according to a study published online June 18 in the Annals of Internal Medicine.Yu-Han Chiu, M.D., Sc.D., from the Harvard T.H. C |
HealthDay
18 June at 09.50 AM
Pandemic-Era Tax Credits Made Healthcare More Affordable, But They're Set to ExpireIn a success story for Americans seeking affordable healthcare coverage, tax credits put in place during the pandemic helped millions gain health insurance, a new report found.Trouble is, the credits are set to expire at the end of 2025, noted a research team from the nonprofit Robert Wood Johnson Foundation (RWJ).According to RWJ's <a h |
HealthDay
17 June at 10.55 PM
Paternal Metformin Use Not Linked to Major Congenital MalformationsPaternal use of metformin in monotherapy is not associated with an increased risk for major congenital malformations (MCMs), according to a study published online June 18 in the Annals of Internal Medicine.Ran S. Rotem, Sc.D., from the Harvard T.H. Chan School of Public Health in Boston, and colleagues examined the association between p |
HealthDay
17 June at 04.12 PM
2008 to 2021 Saw Increase in Prevalence of Chronic HTN in PregnancyFor pregnant individuals, the prevalence of chronic hypertension more than doubled between 2008 and 2021, according to a study published online June 17 in Hypertension.Stephanie A. Leonard, Ph.D., from the Stanford University School of Medicine in California, and colleagues analyzed commercial insurance claims from 2007 to 2021 and asse |
HealthDay
17 June at 04.09 PM
Few Receive Meds for Opioid Use Disorder After Nonfatal OverdoseIn the 12 months after a nonfatal overdose, few Medicare beneficiaries receive medications for opioid use disorder (MOUD) or fill a naloxone prescription, according to a study published online June 17 in JAMA Internal Medicine.Christopher M. Jones, Pharm.D., Dr.P.H., from the Substance Abuse and Mental Health Services Administration in |
HealthDay
17 June at 03.58 PM
Survodutide Tied to Significant Improvement in Fatty Liver DiseaseMost patients taking survodutide, a dual agonist of glucagon receptor and glucagon-like peptide-1 (GLP-1) receptor, experience significant improvement in metabolic dysfunction-associated steatohepatitis (MASH) without worsening of fibrosis, according to a phase 2 study published online June 7 in the New England Journal of Medicine to |
HealthDay
17 June at 03.55 PM
Pantoprazole Cuts GI Bleeding in Patients Undergoing Invasive VentilationPantoprazole results in a significantly lower risk for clinically important upper gastrointestinal bleeding than placebo, with no increase in mortality, among patients undergoing invasive ventilation, according to a study published online June 14 in the New England Journal of Medicine to coincide with the annual Critical Care Reviews Meeting, |
HealthDay
14 June at 08.51 PM
FDA Approves Generic Emflaza Oral Suspension for Duchenne Muscular DystrophyThe U.S. Food and Drug Administration has approved the first generic version of Emflaza (deflazacort) oral suspension for Duchenne muscular dystrophy (DMD).Deflazacort oral suspension is a corticosteroid indicated to treat DMD in patients 5 years of age and older but is contraindicated in patients with known hypersensitivity to deflazacort. The |
HealthDay
14 June at 03.35 PM
Prolonged β-Lactam Antibiotic Infusions Aid Sepsis, Septic Shock OutcomesAmong adults in the intensive care unit with sepsis or septic shock, the use of prolonged β-lactam antibiotic infusions is associated with lower risk of 90-day mortality compared with intermittent infusions, according to research published online June 12 in the Journal of the American Medical Association to coincide with the annual C |
HealthDay
14 June at 03.32 PM
No Evidence That Live Vaccines Are Unsafe for Patients on DupilumabThere is no evidence to suggest that administration of live vaccines to patients receiving dupilumab is unsafe, and vaccine efficacy is not affected by dupilumab, according to a position paper published online June 5 in the Annals of Allergy, Asthma & Immunology.Noting that dupilumab targets the interleukin (IL)-4 receptor alpha sub |
HealthDay
14 June at 12.05 PM
ADHD Patients Could Face Disrupted Access to Meds Following Fraud CaseThe two top officers of a telehealth company that began to distribute ADHD drugs widely during the pandemic have been charged with health care fraud, the U.S. Department of Justice announced Thursday.The arrests will likely worsen ongoing shortages of Adderall and another ADHD medication, Vyvanse, experts said.“There are a |
HealthDay
14 June at 10.50 AM
FDA Tells Vaccine Makers to Target New COVID Variant for FallCOVID vaccine makers will be advised to update their shots to target the KP.2 variant, an offshoot of the JN.1 variant that spread widely last winter, the U.S. Food and Drug Administration announced Thursday.It's a turnaround for the agency: The <a href="https://www.fda.gov/vaccines-blood-biologics/updated-covid-19-vaccines-use-united-states-beg |
HealthDay
13 June at 10.58 PM
Health Care Spending Growth Projected to Outpace GDP to 2032Health care spending growth is projected to outpace that of the gross domestic product (GDP) during the coming decade, according to a study published online June 12 in Health Affairs.Jacqueline A. Fiore, Ph.D., from the Centers for Medicare & Medicaid Services in Baltimore, and colleagues projected growth in national health expend |
HealthDay
13 June at 04.10 PM
GLP-1 RA Use Linked to Lower Quality of Bowel PreparationThe use of glucagon-like peptide 1 receptor agonists (GLP-1 RAs) for diabetes or obesity is associated with a lower quality of bowel preparation among patients undergoing colonoscopy, according to a study published online in the June issue of the American Journal of Gastroenterology.Rebecca Yao, M.D., M.P.H., from the Mayo Clinic in R |
HealthDay
13 June at 03.54 PM
Alternative Pembrolizumab Administration Yields Environmental AdvantagesAlternative pembrolizumab administration strategies may have environmental advantages, such as less carbon dioxide emission, according to a study published in the June issue of The Lancet Oncology.Alex K. Bryant, M.D., from the Veterans Affairs Center for Clinical Management Research in Ann Arbor, Michigan, and colleagues conducted a |
HealthDay
13 June at 03.46 PM
Tirzepatide Beneficial for Resolution of MASH in Patients With MASH, FibrosisFor patients with metabolic dysfunction-associated steatohepatitis (MASH) and moderate-to-severe fibrosis, 52 weeks of tirzepatide is more effective than placebo for resolution of MASH, according to a study published online June 8 in the New England Journal of Medicine to coincide with the annual congress of the European Association for the |
HealthDay
13 June at 03.30 PM
Supreme Court Rejects Case That Would Have Curbed Access to Abortion DrugThe U.S. Supreme Court on Thursday threw out a case that aimed to curb access to the controversial abortion drug mifepristone, saying the plaintiffs who brought the case to the court had no legal standing to do so.In a unanimous vote, the nine judges <a href="https://www.supremecourt.gov/op |
HealthDay
13 June at 11.17 AM
J&J Settles Talcum Powder Lawsuits From States for $700 MillionJohnson & Johnson will pay $700 million to settle claims from 42 states and the District of Columbia that the company continued to market its talcum powder products even as evidence tied them to a heightened risk for cancer.J&J did not admit to any wrongdoing in settling with the states, which were led by Florida, Texas and North Carol |
HealthDay
12 June at 02.55 PM
Patients Can Take GLP-1 RA Medications Before SurgeryGlucagon-like peptide-1 receptor agonist (GLP-1 RA) medications do slow gastric emptying but not by enough to warrant discontinuing medications before surgery, according to a review published in the June issue of the American Journal of Gastroenterology.Brent Hiramoto, M.D., from Brigham and Women's Hospital in Boston, and colle |
HealthDay
12 June at 02.52 PM
ENDO: Novel Male Contraceptive Gel May Achieve Faster Sperm SuppressionA novel male contraceptive gel suppresses sperm production faster than other hormone-based methods for male birth control, according to a phase 2 study presented at the annual meeting of the Endocrine Society, held from June 1 to 4 in Boston.Danielle Gross, from the Eunice Kennedy Shriver National Institute of Child Health and Human Developme |
HealthDay
11 June at 03.58 PM
Systemic Side Effects of COVID-19 Vaccine Tied to Greater nAB ResponseShort-term systemic side effects of the severe acute respiratory coronavirus 2 (SARS-CoV-2) mRNA vaccine are associated with greater long-lasting neutralizing antibody (nAB) responses, according to a study published online June 11 in the Annals of Internal Medicine.Ethan G. Dutcher, M.D., Ph.D., from the University of California, San F |
HealthDay
11 June at 03.54 PM
Melatonin Use Linked to Reduced Risk for Development, Progression of AMDMelatonin use is associated with a reduced risk for development and progression of age-related macular degeneration (AMD), according to a study published online June 6 in JAMA Ophthalmology.Hejin Jeong, from the Case Western Reserve University School of Medicine in Cleveland, and colleagues conducted a retrospective cohort study to exa |
HealthDay
11 June at 03.48 PM
No Link Seen Between Exposure to Immunosuppressive Therapy, Cancer in IBD PatientsThere is no significant association between exposure to immunosuppressive therapies and development of incident cancers among patients with inflammatory bowel disease (IBD) and a history of cancer, according to a study published online May 18 in Clinical Gastroenterology and Hepatology.Steven H. Itzkowitz, M.D., from the Icahn School o |
HealthDay
11 June at 03.45 PM
ENDO: Teprotumumab Shows Long-Term Efficacy for Thyroid Eye DiseaseMost patients with thyroid eye disease treated with teprotumumab do not require additional treatments nearly two years later, according to a study presented at the annual meeting of the Endocrine Society, held from June 1 to 4 in Boston, and simultaneously published online June 2 in Thyroid.George J. Kahaly, M.D., Ph.D., from the |
HealthDay
11 June at 12.58 PM
FDA Advisors Support New Alzheimer's DrugA U.S. Food and Drug Administration advisory panel voted unanimously on Monday to recommend that the benefits of a new drug for Alzheimer's outweigh its harms, which can include brain swelling and bleeding.Eli Lilly's donanemab did slow declines in thinking skills in patients with early-stage Alzheimer's: <a href="https://www.fda.gov/media/1791 |
HealthDay
10 June at 03.28 PM
Greater Reduction Seen in Mortality With Bariatric Surgery Than GLP-1 RAsBariatric metabolic surgery (BMS) is associated with a greater reduction in mortality than glucagon-like peptide-1 receptor agonist (GLP-1 RA) treatment among adults with a diabetes duration of 10 years or less, according to a study published online June 7 in JAMA Network Open.Dror Dicker, M.D., from Rabin Medical Center in Petah Tikva, |
HealthDay
10 June at 03.22 PM
Vitamin D Suggested for Children, Seniors, Those With High-Risk PrediabetesEmpiric vitamin D supplementation is suggested for those aged 1 to 18 years, those older than 75 years, those who are pregnant, and those with high-risk prediabetes, according to an Endocrine Society clinical practice guideline published online June 3 in the Journal of Clinical Endocrinology & Metabolism.Marie B. Demay, M.D., from M |
HealthDay
10 June at 03.10 PM
New Clinical Score Can Predict Immune Checkpoint Blockade ResponseFor patients with cancer, a novel clinical score using a six-feature regression model can predict immune checkpoint blockade (ICB) response probability and patient survival, according to a study published online June 3 in Nature Cancer.Tian-Gen Chang, Ph.D., from the National Institutes of Health in Bethesda, Maryland, and colleagues an |
HealthDay
10 June at 03.07 PM
Nirmatrelvir-Ritonavir No Aid for Long COVID SymptomsA 15-day course of nirmatrelvir-ritonavir (NMV/r) is safe but does not demonstrate a significant benefit for improving postacute sequelae of SARS-CoV-2 infection (PASC) symptoms, according to a study published online June 7 in JAMA Internal Medicine to coincide with the Demystifying Long COVID North American Conference 2024, held from Jun |
HealthDay
10 June at 03.03 PM
Bulevirtide + Peginterferon Alfa-2a Best Treatment for Chronic Hepatitis DThe combination of bulevirtide plus peginterferon alfa-2a is superior to bulevirtide monotherapy for achieving undetectable hepatitis D virus (HDV) RNA level at 24 weeks after the end of treatment in patients with chronic hepatitis D, according to a study published online June 6 in the New England Journal of Medicine to coincide with the |
HealthDay
10 June at 01.02 PM
FDA Gives Nod to RSV Vaccine for People in Their 50sThe U.S. Food and Drug Administration on Friday has for the first time approved the use of a respiratory syncytial virus (RSV) vaccine for people in their 50s who are at increased risk for the illness.Drugmaker GSK's Arexvy vaccine, as well as vaccines from Pfizer and Moderna, are already approved |
HealthDay
10 June at 12.22 PM
Moderna Announces Good Results From Trial of Combo COVID/Flu VaccineAn experimental vaccine that could offer one-stop prevention for both COVID-19 and influenza is showing positive results among older adults in trials, maker Moderna announced Monday.The shot — for now called mRNA-1083 — "has met its primary endpoints, eliciting a higher immune response than the licensed comparator vaccines used in the trial," Mo |
HealthDay
07 June at 03.34 PM
ASCO: Germline Variation Does Not Predict Taxane-Induced Peripheral NeuropathyGermline variation does not predict the risk of taxane-induced peripheral neuropathy (TIPN) in Black women receiving paclitaxel (once weekly) or docetaxel (every three weeks) for early-stage breast cancer, according to a study published online June 3 in the Journal of Clinical Oncology to coincide with the annual meeting of the American Society |
HealthDay
07 June at 03.34 PM
ENDO: Cardiovascular Events Occur Less Often With GLP1-RA, SGLT-2i for T2D, Liver DiseaseFor adults with type 2 diabetes (T2D) and metabolic dysfunction-associated steatotic liver disease (MASLD), glucagon-like peptide 1 receptor agonists (GLP-1 RA) and sodium-glucose cotransporter 2 inhibitors (SGLT-2i) are associated with reduced risk of cardiovascular (CV) events compared with dipeptidyl peptidase 4 inhibitors (DPP-4i), according to a st |
HealthDay
07 June at 03.33 PM
Isotretinoin Effective for Acne in Those Receiving Gender-Affirming TherapyIsotretinoin is well tolerated and effective for individuals receiving masculinizing gender-affirming hormonal therapy who have acne, according to a study published online May 29 in JAMA Dermatology.James Choe, from Brigham and Women's Hospital in Boston, and colleagues examined clinical outcomes of isotretinoin among transgender and gen |
HealthDay
07 June at 03.32 PM
Mortality in Rheumatic Heart Disease Is HighMortality related to rheumatic heart disease (RHD) is high and is correlated with the severity of valve disease, according to a study published online June 5 in the Journal of the American Medical Association.Ganesan Karthikeyan, D.M., from the All India Institute of Medical Sciences in New Delhi, and colleagues assessed the risk an |
HealthDay
06 June at 04.24 PM
Several Drugs Linked to Risk for Aneurysmal Subarachnoid HemorrhageSeveral commonly prescribed drugs are associated with aneurysmal subarachnoid hemorrhage (aSAH), according to a study published online June 5 in Neurology.Jos P. Kanning, from the University Medical Center Utrecht in the Netherlands, and colleagues conducted a drug-wide association study to examine the association between commonly pres |
HealthDay
06 June at 04.20 PM
Many Patients Have Discontinuation Symptoms After Stopping AntidepressantsA considerable proportion of patients have discontinuation symptoms (e.g., dizziness, headache, nausea, insomnia, and irritability) after discontinuing antidepressants, according to a review published online June 5 in The Lancet Psychiatry.Jonathan Henssler, M.D., from the University of Cologne in Germany, and colleagues conducted |
HealthDay
06 June at 04.12 PM
ASCO: Ivonescimab Improves Progression-Free Survival in EGFR+ Lung CancerFor patients with non-small cell lung cancer with the epidermal growth factor receptor (EGFR) variant, ivonescimab plus chemotherapy improves progression-free survival, according to a study published online May 31 in the Journal of the American Medical Association to coincide with the annual meeting of the American Society of Clinica |
HealthDay
06 June at 12.19 PM
FDA Panel OKs New COVID Vaccine for FallA U.S. Food and Drug Administration advisory panel on Wednesday recommended updating the formula for COVID vaccines ahead of a fall campaign that will encourage Americans to get the latest shots.The unanimous vote recommends that vaccine makers tailor the next vaccine to target the JN.1 variant, which dominated infections in the Unite |
HealthDay
05 June at 09.18 PM
Neoadjuvant Nivolumab, Ipilimumab Safe for dMMR Colon CancerNeoadjuvant nivolumab plus ipilimumab has an acceptable safety profile in patients with locally advanced mismatch repair-deficient (dMMR) colon cancer, according to a study published in the June 6 issue of the New England Journal of Medicine.Myriam Chalabi, M.D., Ph.D., from the Netherlands Cancer Institute in Amsterdam, and colleague |
HealthDay
05 June at 09.15 PM
CDC Recommends Doxycycline PEP for Gay Men, Transgender WomenIn clinical guidelines issued by the U.S. Centers for Disease Control and Prevention and published June 4 in the agency's Morbidity and Mortality Weekly Report, recommendations are presented for the use of doxycycline postexposure prophylaxis (doxy PEP) for preventing sexually transmitted infections (STIs) in gay, bisexual, and other men who |
HealthDay
05 June at 03.31 PM
ASCO: Osimertinib Improves Progression-Free Survival in EGFR-Mutated Lung CancerFor patients with unresectable stage III EGFR-mutated non-small cell lung cancer (NSCLC), treatment with osimertinib results in significantly longer progression-free survival, according to a study published online June 2 in the New England Journal of Medicine to coincide with the annual meeting of the American Society of Clinical On |
HealthDay
05 June at 03.28 PM
ASCO: Neoadjuvant Ipilimumab + Nivolumab Ups Survival in Resectable MelanomaNeoadjuvant ipilimumab plus nivolumab followed by surgery results in longer event-free survival than surgery followed by adjuvant nivolumab among patients with resectable, macroscopic stage III melanoma, according to a study published online June 2 in the New England Journal of Medicine to coincide with the annual meeting of the American Soc |
HealthDay
05 June at 03.26 PM
ASCO: Asciminib Has Superior Efficacy to TKIs for Newly Diagnosed LeukemiaFor patients with newly diagnosed chronic myeloid leukemia (CML), asciminib shows superior efficacy and a favorable safety profile compared with investigator-selected tyrosine kinase inhibitors (TKIs), according to a study published online May 31 in the New England Journal of Medicine to coincide with the annual meeting of the American Socie |
HealthDay
05 June at 03.23 PM
ENDO: Crinecerfont Aids Patients With Congenital Adrenal HyperplasiaCrinecerfont results in a greater decrease from baseline in the mean daily glucocorticoid dose among patients with congenital adrenal hyperplasia (CAH), according to a study published online June 2 in the New England Journal of Medicine to coincide with the annual meeting of the Endocrine Society, held from June 1 to 4 in Boston.Richa |
HealthDay
05 June at 12.45 PM
FDA Panel Says No to MDMA as Treatment for PTSDA U.S. Food and Drug Administration advisory panel on Tuesday voted against recommending the psychedelic MDMA for the treatment of post-traumatic stress disorder (PTSD).In a 10-1 vote, the panel determined the evidence amassed so far fails to show the controversial drug's benefits outweigh its risks, the Associated Press reported. |
|